Literature DB >> 11756807

Bacterial flora of Hirudo medicinalis and their antibiotic sensitivities in the Middle Black Sea Region, Turkey.

C Eroglu1, M Hokelek, E Guneren, S Esen, A Pekbay, O A Uysal.   

Abstract

The rate of infectious complications of leech therapy is almost 20% because Hirudo medicinalis has endosymbiotic bacteria. The aim of this study was to determine the bacterial flora of H. medicinalis and their antibiotic sensitivities in a region in Turkey. Sixteen adult leeches were collected in Middle Black Sea region, Turkey. They were rubbed onto blood agar plates directly under ether anesthesia to obtain surface cultures. They were then killed to obtain mouth and gut cultures. Culture swabs were applied to blood agar, eosin methylene blue agar, and ampicillin blood agar plates. Gut contents were applied to blood culture medium as well. Bacteria were isolated in 15 of 16 leech surfaces, in 7 of 16 mouths, and in 15 of 16 guts. Isolated bacteria were identified with Analytical Profile Index 32 E and Analytical Profile Index 20 NE (fermentative and nonfermentative respectively). Most common types of cultured bacteria were Aeromonas hydrophila (N = 25), Ochrobacter anthropi (N = 23), nonfermenting Gram-negative rods (N = 12), Acinetobacter lwoffi (N = 3), and A. sobria (N = 2) in 73 isolates. A standard disk diffusion test was performed on isolated bacteria. All isolates were 100% susceptible to ciprofloxacin, cefotaxime, ceftazidime, gentamicin, and trimethoprim/sulfamethoxazole. Because leeches are carriers of Aeromonas and other bacteria, appropriate antibiotic prophylaxis should be administrated to the patient who needs leech therapy. Antibacterial agents can be determined by the resistance pattern of the bacterial flora of regional H. medicinalis.

Entities:  

Mesh:

Year:  2001        PMID: 11756807     DOI: 10.1097/00000637-200107000-00013

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  Spatial and temporal population dynamics of a naturally occurring two-species microbial community inside the digestive tract of the medicinal leech.

Authors:  Yoshitomo Kikuchi; Joerg Graf
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

2.  Infection risk related to the use of medicinal leeches.

Authors:  Tiene G M Bauters; Franky M A Buyle; Gerda Verschraegen; Karen Vermis; Dirk Vogelaers; Geert Claeys; Hugo Robays
Journal:  Pharm World Sci       Date:  2007-03-13

3.  Culture-independent characterization of the digestive-tract microbiota of the medicinal leech reveals a tripartite symbiosis.

Authors:  Paul L Worthen; Cindy J Gode; Joerg Graf
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

4.  Medicinal leech therapy and Aeromonas spp. infection.

Authors:  B Verriere; B Sabatier; E Carbonnelle; J L Mainardi; P Prognon; I Whitaker; L Lantieri; M Hivelin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

5.  Leech Therapy for Treating Priapism: Case Report.

Authors:  Sayed Aladdin Asgari; Sadeq Rostami; Mojtaba Teimoori
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

6.  External decontamination of wild leeches with hypochloric acid.

Authors:  Atakan Aydin; Hasan Nazik; Samet Vasfi Kuvat; Nezahat Gurler; Betigul Ongen; Serdar Tuncer; Emre Hocaoglu; Sinan Nur Kesim
Journal:  BMC Infect Dis       Date:  2004-08-25       Impact factor: 3.090

7.  Leech therapy for epidermoid cysts and review of the literature.

Authors:  Abbas Rasi; Alireza Faghihi; Mirhadi Aziz Jalali; Abbas Zamanian; Gholamhossein Ghaffarpour
Journal:  Adv Biomed Res       Date:  2014-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.